Kurt Schönfeld

Biotest (Germany) — Germany

Medicine · Health Sciences

13h-index2.3kcitations33works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(10), Immune Cell Function and Interaction(9), Immunotherapy and Immune Responses(7), Monoclonal and Polyclonal Antibodies Research(6), T-cell and B-cell Immunology(3)

Publications32 total

Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate
PLoS ONE·2018· 25 citedOpen Access
Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models
Pharmaceutical Research·2018· 23 citedOpen Access
Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies
Journal of Hematology & Oncology·2017· 56 citedOpen Access
Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64+ cells
Scientific Reports·2015· 5 citedOpen Access
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
JNCI Journal of the National Cancer Institute·2015· 377 citedOpen Access
Expression of CD138 / syndecan-1 in triple-negative breast cancer – correlative study of GeparSixto
Annals of Oncology·2015· 1 cited
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Molecular Therapy·2014· 338 citedOpen Access
O6.05 * ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA
Neuro-Oncology·2014Open Access
ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA
Neuro-Oncology·2014· 2 citedOpen Access
Abstract 3967: ErbB2/HER2-specific natural killer cells for adoptive immunotherapy of glioblastoma.
Cancer Research·2013
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Molecular Therapy — Nucleic Acids·2013· 450 citedOpen Access
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
Journal for ImmunoTherapy of Cancer·2013Open Access
METHODS: ORIGINAL ARTICLE TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
2013
T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing
Blood·2012· 67 citedOpen Access
Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
Cancer Immunology Immunotherapy·2012· 179 citedOpen Access
NK cells engineered to express a GD<sub>2</sub>‐specific antigen receptor display built‐in ADCC‐like activity against tumour cells of neuroectodermal origin
Journal of Cellular and Molecular Medicine·2011· 183 citedOpen Access
Inhibition of Melanoma Growth by Targeting of Antigen to Dendritic Cells via an Anti-DEC-205 Single-Chain Fragment Variable Molecule
Clinical Cancer Research·2008· 64 cited
Fine structural characterization of cloned human endogenous retrovirus HERV-K113
2008
Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles
Journal of General Virology·2008· 141 cited
Induction of immunosuppressive functions of dendritic cells <i>in vivo</i> by CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells: Role of B7‐H3 expression and antigen presentation
European Journal of Immunology·2007· 131 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Winfried S. Wels(11), Torsten Tonn(7), Christiane Sahm(5), Manuel Grez(5), Michael C. Burger(4), Sabrina Genßler(4), Sonja Naundorf(4), Marcus Odendahl(4), Congcong Zhang(3), Lukas Jennewein(3), Michel Mittelbronn(3), Christian Brendel(3), Paulina Nowakowska(3), Ulrike Köhl(3), Karsten Mahnke(3), Sabine Ring(3), Theron Johnson(3), Volker Storn(3), Alexander Enk(3), Christoph Uherek(3)